News Agency
Men's Weekly

Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study

  • Written by PR Newswire

HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK01004.

The trial was designed to evaluate the safety,...

Read more: Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib...

Defense Industry Jobs and Defence Recruitment: Building Careers That Shape National Security

The defence sector is one of the most important contributors to national security, innovation, and economic growth. Across Australia and worldwide, defense industry jobs offer opportunities for individuals to work in fields that combine technology, strategy, and service to the nation... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion